Donisi Health

Donisi Health was an Israel-based MedTech company focused on contact-free remote monitoring for patients with congestive heart failure and other chronic cardiopulmonary conditions. Its core product, the FDA-cleared Gili Pro BioSensor, used optical sensing, cloud analytics, and artificial intelligence to measure cardiopulmonary parameters without wires, wearables, or patches. The company positioned its technology as an in-home early warning system for pulmonary congestion and heart-failure deterioration, with the goal of reducing avoidable rehospitalizations. Donisi presented clinical data supporting detection of pulmonary congestion in CHF patients and marketed the system to healthcare organizations involved in home-based monitoring and chronic care management. Public company databases indicate the business was private and is now closed.